FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to tablet, which is decomposed in mouth, containing D-mannite, active ingredient, disintegrating preparation, selected from crospovidone and carmellose, lubricant, selected from sodium stearylfumarate and sucrose esters of fatty acids, binding agent and starch. D-mannite has average size of particles larger than 30 mcm and specific surface larger than 0.40 m2/g.
EFFECT: claimed tablet has time of decomposition in oral cavity within 30 seconds, excellent sensation in oral cavity and sufficient strength, as a result of which tablet is not decomposed in the process of distribution.
28 cl, 1 dwg, 12 tbl, 51 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DRY COATED TABLET, CONTAINING TEGAFUR, GIMERACIL AND POTASSIUM OTERACIL | 2012 |
|
RU2601620C2 |
| SOLID PHARMACEUTICAL COMPOSITION CONTAINING 1-(3-(2-(1-BENZOTHIOPHENE-5-YL)ETOXY)PROPYL)AZETIDINE-3-OL OR ITS SALT | 2013 |
|
RU2625767C2 |
| ORALLY DISPERSIBLE MANNITOL | 2009 |
|
RU2500388C2 |
| ANTACID AND LAXATIVE TABLET | 2010 |
|
RU2501561C1 |
| QUICKLY DECOMPOSING, PRESSED IN FORMS MATERIALS AND METHOD OF THEIR PREPARING | 1997 |
|
RU2189227C2 |
| ORALLY DISINTEGRATING TABLET TEMAZEPAM COMPOSITIONS | 2008 |
|
RU2524638C2 |
| RASAGILINE COMPOSITIONS DEGRADING IN MOUTH CAVITY | 2005 |
|
RU2389482C2 |
| PILL CONTAINING 1-(3-(2-(1-BENZOTHIOPHEN-5-YL)ETHOXY)PROPYL)AZETIDIN-3-OL OR ITS SALTS | 2016 |
|
RU2733404C2 |
| CORTICOSTEROID-CONTAINING ORALLY DISINTEGRATING TABLET COMPOSITIONS FOR TREATING EOSINOPHILIC ESOPHAGITIS | 2014 |
|
RU2678695C2 |
| DIRECTLY PRESSIBLE AND RAPIDLY-DECOMPOSABLE TABLET MATRIX | 2009 |
|
RU2519768C2 |
